About Aseptuva
Data last updated:
Aseptuva is a company based in Bern (Switzerland) founded in 2021 by Henry Twerenbold. Aseptuva has raised $6.02 million across 3 funding rounds from investors including Convert2Green and MedPhab. Aseptuva offers products and services including Disinfection Adaptors. Aseptuva operates in a competitive market with competitors including Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
- Headquarter Bern, Switzerland
- Founders Henry Twerenbold
- SectorsHealthcare
- EmailLocked
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Annual RevenueNot available
- Net ProfitNot available
- EBITDANot available
- Total Equity Funding$6.02 M (USD)
in 3 rounds
- Latest Funding Round$6.02 M (USD), Series A
Sep 22, 2026
- InvestorsConvert2Green
& 1 more
- Employee CountNot available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aseptuva
Aseptuva offers a comprehensive portfolio of products and services, including Disinfection Adaptors.
Automated adaptors using Far-UVC to prevent bacterial infections at entry sites.
Funding Insights of Aseptuva
Aseptuva has successfully raised a total of $6.02M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6.02 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aseptuva
Aseptuva has secured backing from 2 investors. Prominent investors backing the company include Convert2Green and MedPhab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Convert2Green is focused on accelerating SME innovations in Europe. | Locked | Locked | Locked | |
MedPhab is focused on photonics-based medical diagnostics development. | Locked | Locked | Locked |
Investor details for Aseptuva
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aseptuva
Investment portfolio details for Aseptuva
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aseptuva
Detailed financials for Aseptuva
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aseptuva Comparisons
Peer comparison for Aseptuva
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aseptuva
Aseptuva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Provider of healthcare consulting services | |
| Locked | Locked | Locked | Medical insurance services for patients and employees are provided. | |
| Locked | Locked | Locked | Business support and supply chain management services are offered. | |
| Locked | Locked | Locked | Advisory services are offered to U.S. healthcare providers. | |
| Locked | Locked | Locked | Provider of comprehensive sterilization solutions and expert consulting services | |
| Locked | Locked | Locked | Contract manufacturing is provided for life sciences and diagnostics reagents. |
Detailed competitors of Aseptuva
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aseptuva
Complete news archive for Aseptuva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aseptuva
Aseptuva was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Aseptuva is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
Henry Twerenbold is the current CEO of Aseptuva. They have also founded this company.
Aseptuva is a funded company, having raised a total of $6.02M across 3 funding rounds to date.
Aseptuva was founded in 2021 in Bern, Switzerland, within the medtech sector. Automated plug-and-play disinfection adaptors based on Far-UVC technology are provided by the company to address pathogenic colonization around catheters. Operations focus on in-situ solutions for reducing hospital-acquired infections, with deployment targeted at healthcare settings. The technology integrates directly into medical devices for ongoing pathogen control.
Aseptuva's top competitors include Qualicorp, Heartland Dental and Argonautms.
Aseptuva offers Disinfection Adaptors.
Aseptuva has 2 investors. Key investors include Convert2Green, and MedPhab.